In the digital world products, services and knowledge travel fast, and where they go so do intangible assets. Understanding which companies, industries and brands rely
Tag: Johnson & Johnson
Former AUTM head cautions exercising ‘march-in’ rights on Covid-related patents
Confiscating taxpayer-funded invention rights would damage the innovation ecosystem that has generated breakthrough therapies and enabled scientists to work so quickly on Covid-19. This is
J&J says it is 5 months away from human trials on a Vaccine; Researchers Float License-Free COVID-19 Pledge
Johnson & Johnson, the pharmaceutical giant, said yesterday it is five months away from starting human trials on a COVID-19 vaccine that would be offered
Post-election “Patent Law & Policy” conference to be held in Washington
Many businesses are wondering what the patent terrain will look like after the U.S. elections in November. Will further reforms will be forthcoming, or will
Pharma Cos Face "Patent Cliff" as Protection Expires
Ten Blockbusters will End in Two Years – An article in Daily Finance says that patents that are expiring on many top-selling drugs will cause pharmaceutical
